Ignite Creation Date:
2025-12-25 @ 1:47 AM
Ignite Modification Date:
2026-02-21 @ 9:48 PM
Study NCT ID:
NCT02925494
Status:
COMPLETED
Last Update Posted:
2021-07-13
First Post:
2016-09-24
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
An Extension Study to Evaluate the Efficacy and Safety of Elagolix in Premenopausal Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids
Sponsor:
AbbVie
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-09-14
Start Date Type:
ACTUAL
Primary Completion Date:
2018-05-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-03-22
Completion Date Type:
ACTUAL
First Submit Date:
2016-09-24
First Submit QC Date:
None
Study First Post Date:
2016-10-06
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2020-06-12
Results First Submit QC Date:
None
Results First Post Date:
2020-06-30
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2019-04-12
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2021-07-09
Last Update Post Date:
2021-07-13
Last Update Post Date Type:
ACTUAL